Clinical trial
A Multicenter, Prospective, Randomized Trial of the Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma
NCT01820858 is registered in ClinicalTrials.gov with Ding Ma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Randomized Trial of the Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma
- Lead sponsor
- Ding Ma
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- November 30, 2012
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.